Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors (Q35978394)

11 August 2017

Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors (English)

1 reference

11 August 2017

S Marsigliante

1

1 reference

11 August 2017

L Biscozzo

2

1 reference

11 August 2017

M Correale

3

1 reference

11 August 2017

A Paradiso

4

1 reference

11 August 2017

G Leo

5

1 reference

11 August 2017

I Abbate

6

1 reference

11 August 2017

C D Dragone

7

1 reference

11 August 2017

C Storelli

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

69

1 reference

11 August 2017

3

1 reference

11 August 2017

550-554

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.100

11 August 2017

0 references

cites work

Evaluation of cathepsin D as a prognostic factor in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Progesterone receptors as a prognostic factor in Stage II breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Primary structure of human protein pS2

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Prediction of relapse and survival in breast cancer patients by pS2 protein status

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

The role of cathepsin D in the invasiveness of human breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Cathepsin D in breast cancer: a tissue marker associated with metastasis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Cathepsin D and prognosis in breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968878

Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer

24 September 2018

1 reference

12 December 2020

A secreted glycoprotein induced by estrogen in human breast cancer cell lines

1 reference

12 December 2020

Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor

1 reference

12 December 2020

Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes

1 reference

12 December 2020

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

1 reference

12 December 2020

Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells

1 reference

12 December 2020

Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells

1 reference

12 December 2020

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

1 reference

12 December 2020

Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness

1 reference

12 December 2020

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

12 December 2020

pS2 expression and response to hormonal therapy in patients with advanced breast cancer

1 reference

12 December 2020

Immunoradiometric assay of pS2 protein in breast cancer cytosols

1 reference

12 December 2020

Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer

1 reference

12 December 2020

Relation of cathepsin D level to the estrogen receptor in human breast cancer

1 reference

12 December 2020

pS2 protein and steroid hormone receptors in invasive breast carcinomas

1 reference

12 December 2020

Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.100

1 reference

11 August 2017

1 reference

11 August 2017

1 reference